Georgia Life Sciences Summit a Huge Success
Tuesday, October 09, 2012
Posted by: Angela King
Atlanta, GA (October 9, 2012) – The 11th annual Georgia Life Sciences Summit, Oct. 3, 2012, was a huge success with more than 600 attendees, 70 speakers and keynote addresses by Johnson & Johnson CEO Alex Gorsky and Baxter Healthcare’s Brien Johnson, Vice President, Program Manager, Plasma Bioscience.
The Summit also featured the release of the 2012 Georgia Life Sciences Industry Analysis, Shaping Infinity, produced by the University of Georgia’s Selig Center for Economic Growth. The analysis, the sixth in a series, shows that one out of every 40 jobs in Georgia is tied to the life sciences industry and during the Great Recession employment was stable, helping to offset the decline in jobs across all other industry sectors. The report also includes articles by Georgia Department of Economic Development Commissioner Chris Cummiskey, UCB’s North American Operations President Greg Duncan and Piedmont Heart Institute’s Innovation Center Board Chair Dr. Charles Wilmer.
The Summit featured a variety of elements, including a BioCareer Resource Center, a special session on National Cancer Institute SBIR grants, a sold out exhibit hall, scientific poster contest and 12 panel sessions in four subject tracks: medical technology and devices; changing landscape of the pharmaceutical industry; therapeutics, diagnostics and vaccines; and new and exciting science at Georgia’s universities.
Four scientists were selected from more than 70 contestants for the Anthony Shuker Scientific Poster Awards. The winners, with titles of their projects, are:
The Biocareer Resource Center included a panel session featuring senior executives discussing their careers followed by one-on-one meetings for job seekers with career counselors. Six counselors held more than 40 one-on-one meetings. In the special session on SBIR grants, NCI program directors held more than 10 one-on-one meetings with local startup companies seeking funding. The Summit exhibit hall was a sell-out again this year.
- Chris Cornelison, Georgia State University (Evaluation of Biological and Chemical Control Options for Geomyces Destructans);
- Shubha Kayarthodi, Morehouse School of Medicine (Molecular Mechanism of Inactivation of Nuclear Receptor Function in ERG-positive Ewing Sarcoma);
- Edward Marchan, Emory University School of Medicine (Multileaf Collimator-Based Linac Radiosurgery for Arteriovenous Malformations-the Emory Experience);
- Lisa McGinley, Georgia Institute of Technology (Mesenchymal Stem Cells Enhance Endothelial-like Behavior of a Partially Differentiated Population of Embryonic Stem Cells); and
- Kausar Samli, The University of Georgia (Engineering a High Affinity Carbohydrate-Recognizing Protein via in silico Modeling and in vitro Directed Evolution)
The Georgia Life Sciences Summit is held each fall. It has become a premier bioscience conference in the Southeast with CEOs, senior executives, investors, scientists and public policy officials from Georgia and across the nation. It is the one-time each year academia, industry and government come together to showcase Georgia’s leadership in bioscience innovation.
Georgia Bio (www.gabio.org) is the private, non-profit association representing the life sciences industry. Members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of products and services that improve the health and well-being of people, animals and the environment.